Effects of U50488H on ventricular arrhythmias induced by myocardial ischemia and reperfusion in rats
Zhu Yun
Abstract
Zhu Yun
Abstract
AIM: To investigate the effects of U50488H (a selective к-opioid receptor agonist) on ventricular arrhythmias induced by myocardial ischemia and reperfusion in rats. METHODS: Rats were randomly divided into four groups, i.e., control group, ischemia/reperfusion group (Ⅰ/R), U50488H group and U50488H+Ⅰ/R group respectively. Heart rate (HR), arterial blood pressure (ABP), left ventricular pressure (LVP), contractive function (+dp/dt max ) and diastolic function (-dp/dt max ) were examined in rats. The incidence of ventricular arrhythmias and arrhythmia score were also determined. RESULTS: ① HR, ABP, LVP and ±dp/dt max in rats decreased with the administration of U50488H; ② intravenous injection of U50488H before Ⅰ/R lowered the incidence of ventricular arrhythmias and arrhythmia score (P0.05). The effect of U50488H was abolished in the presence of Nor-BNI, a selective κ-opioid receptor antagonist. CONCLUSION: κ-opioid receptor stimulation by U50488H alters the cardiac rhythm and reduces the occurrence of ventricular arrhythmia induced by myocardial ischemia and reperfusion.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM: To investigate the effects of U50488H (a selective к-opioid receptor agonist) on ventricular arrhythmias induced by myocardial ischemia and reperfusion in rats. METHODS: Rats were randomly divided into four groups, i.e., control group, ischemia/reperfusion group (Ⅰ/R), U50488H group and U50488H+Ⅰ/R group respectively. Heart rate (HR), arterial blood pressure (ABP), left ventricular pressure (LVP), contractive function (+dp/dt max ) and diastolic function (-dp/dt max ) were examined in rats. The incidence of ventricular arrhythmias and arrhythmia score were also determined. RESULTS: ① HR, ABP, LVP and ±dp/dt max in rats decreased with the administration of U50488H; ② intravenous injection of U50488H before Ⅰ/R lowered the incidence of ventricular arrhythmias and arrhythmia score (P0.05). The effect of U50488H was abolished in the presence of Nor-BNI, a selective κ-opioid receptor antagonist. CONCLUSION: κ-opioid receptor stimulation by U50488H alters the cardiac rhythm and reduces the occurrence of ventricular arrhythmia induced by myocardial ischemia and reperfusion.
Key concepts: Agonist, Medicine, Internal medicine, Ischemia, Cardiology, Ventricular pressure, Antagonist, Blood pressure